TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. The company also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes. In addition, it provides product development services to medical device manufacturers and others that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification services. The company was founded in 1998 and is headquartered in Quebec, Canada.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-418-6510003
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$7.19 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date3/28/2019 (Confirmed)
OptionableNot Optionable
TSO3 (TSE:TOS) Frequently Asked Questions
What is TSO3's stock symbol?
TSO3 trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TOS."
When is TSO3's next earnings date?
What price target have analysts set for TOS?
3 analysts have issued 1 year target prices for TSO3's shares. Their forecasts range from C$0.80 to C$2.00. On average, they anticipate TSO3's share price to reach C$1.29 in the next year. This suggests a possible upside of 173.9% from the stock's current price. View Analyst Price Targets for TSO3.
What is the consensus analysts' recommendation for TSO3?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TSO3 in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for TSO3.
Has TSO3 been receiving favorable news coverage?
News headlines about TOS stock have been trending somewhat negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. TSO3 earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future.
Who are some of TSO3's key competitors?
Some companies that are related to TSO3 include Tristel (TSTL), SDI (SDI), InfuSystem (INFU), Daxor (DXR), Retractable Technologies (RVP), IsoRay (ISR), IsoRay (ISR), Omega Diagnostics Group (ODX), Milestone Scientific (MLSS), Impression Healthcare (IHL), Relevium Technologies (RLV), Vigil Health Solutions (VGL), Akers Biosciences (AKR), ANSELL LTD/S (ANSLY) and CONVATEC GRP PL/ADR (CNVVY).
What other stocks do shareholders of TSO3 own?
Based on aggregate information from My MarketBeat watchlists, some companies that other TSO3 investors own include ProMetic Life Sciences (PLI), Canopy Growth (CGC), OrganiGram (OGI), Bombardier, Inc. Class B (BBD.B), Nemaska Lithium (NMX), Medical Facilities (DR), Micron Technology (MU), Gran Tierra Energy (GTE), Pfizer (PFE) and Sun Life Financial (SLF).
Who are TSO3's key executives?
TSO3's management team includes the folowing people:
- Mr. Richard M. Rumble, Pres, CEO & Director (Age 60)
- Mr. Glen Kayll, Chief Financial Officer (Age 50)
- Mr. Harold R. Tessman, Chief Operations Officer
- Dr. Bradley J. Catalone MBA, Ph.D., Chief Scientific Officer
- Ms. Cindy Clark, Sr. VP of Global Commercialization
How do I buy shares of TSO3?
Shares of TOS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is TSO3's stock price today?
One share of TOS stock can currently be purchased for approximately C$0.47.
How big of a company is TSO3?
TSO3 has a market capitalization of C$43.92 million and generates C$7.19 million in revenue each year.
What is TSO3's official website?
How can I contact TSO3?
TSO3's mailing address is 2505 Dalton Ave, QUEBEC, QC G1P 3S5, Canada. The company can be reached via phone at +1-418-6510003.
MarketBeat Community Rating for TSO3 (TSE TOS)
MarketBeat's community ratings are surveys of what our community members think about TSO3 and other stocks. Vote "Outperform" if you believe TOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TOS will underperform the S&P 500 over the long term. You may vote once every thirty days.
